Skip to content
Longterm Wiki

Kainomyx — Antimalarial Drug (2025)

grantVerified

Metadata

Source Tablegrants
Source ID0eYHlOhm__
Descriptionto Kainomyx, USD 900000, 2024-12
Source URLcoefficientgiving.org/funds/
ParentCoefficient Giving
Children
CreatedMar 12, 2026, 5:54 AM
UpdatedMar 22, 2026, 2:59 AM
SyncedMar 19, 2026, 8:57 PM

Record Data

id0eYHlOhm__
organizationIdCoefficient Giving(organization)
granteeIdKainomyx
orgEntityIdCoefficient Giving(organization)
orgDisplayName
granteeEntityId
granteeDisplayNameKainomyx
nameKainomyx — Antimalarial Drug (2025)
amount900000
currencyUSD
period
date2024-12
status
sourcecoefficientgiving.org/funds/
notes[Scientific Research] Open Philanthropy recommended an investment of $899,999 in Kainomyx to discover and develop novel therapeutics with unique mechanisms of action to treat malaria and other parasitic diseases. If effective, the new drugs would act by inhibiting cytoskeletal proteins in malarial a
programIdB4pZkOtjSk
dataSourceId

Source Check Verdicts

confirmed95% confidence

Last checked: 4/29/2026

1 → confirmed

Debug info

Thing ID: 0eYHlOhm__

Source Table: grants

Source ID: 0eYHlOhm__

Parent Thing ID: sid_ULjDXpSLCI